An FDA report on bioresearch monitoring FY 2023 metrics documents nearly 1,100 inspections through FDAs five Centers.
The United States Court of Appeals for the DC Circuit grants a Novartis motion to stay FDAs approval of MSN Laboratories generic version of Novartiss ...
A New York Times investigative article examines potential conflicts of interest with retiring CDRH director Jeff Shuren and his lawyer wife who repres...
FDA approves an Abbott labeling change on its HeartMate 3 heart pump to eliminate aspirin as part of routine patient management.
The Federal Trade Commission says it supports an FDA draft guidance easing the approval requirements for interchangeable biosimilar drugs.
The Government Accountability Office says FDA has faced challenges in its preparations for beginning active postmarket surveillance of medical devices...
Four House Democrats and Republicans urge FDA to take a greater role in protecting U.S. national security interests that could be at risk when drug co...
FDA warns Indias Eugia Pharma Specialties about CGMP violations in its production of finished drugs.
